Enovis Corp Correlations
ENOV Stock | USD 46.17 1.39 3.10% |
The current 90-days correlation between Enovis Corp and Helios Technologies is 0.63 (i.e., Poor diversification). The correlation of Enovis Corp is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
Enovis Corp Correlation With Market
Poor diversification
The correlation between Enovis Corp and DJI is 0.64 (i.e., Poor diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Enovis Corp and DJI in the same portfolio, assuming nothing else is changed.
Enovis |
Moving together with Enovis Stock
0.83 | GH | Guardant Health | PairCorr |
0.79 | LH | Laboratory | PairCorr |
0.61 | NEOG | Neogen | PairCorr |
0.62 | UTMD | Utah Medical Products | PairCorr |
Moving against Enovis Stock
0.6 | CVS | CVS Health Corp Aggressive Push | PairCorr |
0.58 | FIGS | Figs Inc | PairCorr |
0.41 | TFX | Teleflex Incorporated | PairCorr |
0.38 | EQ | Equillium | PairCorr |
0.6 | DMAC | DiaMedica Therapeutics | PairCorr |
0.39 | VIRX | Viracta Therapeutics | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Risk-Adjusted Indicators
There is a big difference between Enovis Stock performing well and Enovis Corp Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Enovis Corp's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
HLIO | 1.65 | 0.03 | 0.08 | 0.10 | 1.81 | 3.95 | 19.40 | |||
NPO | 1.46 | 0.03 | 0.07 | 0.10 | 1.74 | 3.40 | 13.16 | |||
OFLX | 1.60 | (0.03) | 0.02 | 0.07 | 1.72 | 3.18 | 11.00 | |||
LXFR | 1.85 | 0.42 | 0.23 | 0.49 | 1.49 | 3.72 | 16.55 | |||
HURC | 1.72 | 0.30 | 0.14 | 0.67 | 1.54 | 4.27 | 18.87 | |||
IEX | 1.05 | 0.08 | 0.09 | 0.15 | 0.85 | 2.38 | 9.79 | |||
WTS | 1.00 | 0.05 | 0.07 | 0.12 | 1.06 | 2.15 | 8.63 | |||
DCI | 0.81 | (0.03) | (0.04) | 0.05 | 0.97 | 1.94 | 5.61 | |||
GRC | 1.31 | (0.06) | 0.01 | 0.05 | 1.52 | 2.38 | 11.59 | |||
EPAC | 1.15 | 0.14 | 0.14 | 0.18 | 1.06 | 2.84 | 12.71 |
Enovis Corp Corporate Management
Michael Macek | VP Relations | Profile | |
Angela Lalor | Director | Profile | |
John Kleckner | Principal Officer | Profile | |
Bradley Tandy | Senior Vice President General Counsel, Corporate Secretary | Profile | |
Liam Kelly | Independent Director | Profile |